The health ministry had formulated the policy in July 2017 and proposed providing the financial aid for one-time treatment of patients with rare diseases.
Modi met senior officials from top drug-makers like Zydus Cadila, Torrent & Wockhardt, and said their non-compliance is forcing govt to create a strict law.
We now live with cheap, bright, artificial light, shift-work, sleep-deprivation – all major challenges to the ancient control mechanisms in our bodies.
In her May 2019 book Bottle of Lies, Katherine Eban accused Indian pharma firms of major lapses such as ‘toxic impurities’ and fudging data on quality control.
Modi govt will soon roll out regulations to check ayurvedic food products whose market is unregulated. A final notification is likely to be issued by February.
Lancet study, conducted in England, focused on individuals aged 10–18 years who went to hospitals after they caused non-fatal self-harm between 1 January 2000 & 31 December 2013.
In 2019, the detection of TB cases in India reached its highest ever at 23.5 lakh patients, against an estimated 26.9 lakh cases.
The US-govt-sponsored study may help Johnson & Johnson's fight against 17,000 lawsuits contending that talc-based personal hygiene products cause ovarian cancer in women.
Lamotrigine is sold in India under more than 20 brand names, including Lamitor, Lametec, Lamosyn and Lamez.
Families accuse doctors of negligence, but Kota's JK Lon Hospital blames the large number of referral cases it gets — "all patients reached us in a very critical situation".